There was no significant difference in TMB between the two tumor entities; astrocytoma exhibited higher mutation rates of ATRX and TP53, and oligodendroglioma presented higher mutated rates of TERT, PTEN and PIK3CA (Fig. 1G, H). This evidence concerns the gene PTEN and astrocytoma (excluding glioblastoma).